Projections indicate this market will reach around USD 1.3 billion in 2025, expanding to USD 2.292.6 billion by the early 2030s
01 Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial Jastreboff AM, Kaplan LM, Frias JP, et al
Show / Hide TOC Table of Contents Why Your Skin Needs Extra Brightening Care in the Winters Skin Brightening Does Not Mean Bleaching What Is Kojic Acid
The risk of bias was described and evaluated in seven specific domains: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting and other biases
The rapid weight loss can be visualized in many areas of the body and one of these manifestations known as Ozempic face occurs when fat pads in the face are rapidly depleted [177,178]
Understanding Tirzepatide and Its Mechanism Tirzepatide, a dual-action injection, operates by activating two key hormonal pathways: GLP-1 and GIP